Research led by Nicolas Bazan, MD, Ph.D., Boyd Professor, Ernest C. and Yvette C. Villere Chair for the Study of Retinal Degeneration, and Director of the Neuroscience Center of Excellence at LSU Health New Orleans School ...
Sep 11, 2023
0
12
Video games could give ophthalmologists an easy window not into the soul, but into eye health and the eye-brain-body connection—the three-way reciprocal communication that influences our actions.
Sep 6, 2023
0
52
Glaucoma and macular degeneration cause blindness in millions of people every year. Hundreds of genes have been implicated for increasing susceptibility to the diseases, and such genes are often starting points for therapies ...
Aug 28, 2023
0
26
The U.S. Food and Drug Administration has approved Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy secondary to age-related macular degeneration.
Aug 10, 2023
0
2
Researchers have developed a novel synthetic protein to treat macular degeneration and other incurable eye diseases that lead to blindness in millions of people. It is the first drug of its kind and is currently in human ...
Jul 25, 2023
0
1
The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon.
Jun 1, 2023
1
104
The RPE and choroid, located behind the human retina, are fundamental to vision, playing a myriad of roles from light absorption to providing oxygenated blood to the photoreceptor cells. However, our understanding of the ...
Jun 1, 2023
0
5
An estimated 295 million people suffer from visual impairment globally. Around 43 million of those people are living with blindness. While not every form of blindness can be cured, recent scientific breakthroughs have uncovered ...
May 12, 2023
0
9
A new research paper titled "Knockout of AMD-associated gene POLDIP2 reduces mitochondrial superoxide in human retinal pigment epithelial cells" has been published in Aging.
Apr 11, 2023
0
3
A drug approved in 2019 for macular degeneration apparently caused rare retinal side effects because of its interactions with the human immune system, two new studies have concluded.
